ConductScience.org, home

Paper · 39480488

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.

Sinha S and 11 others. J Clin Invest, 2024. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels. Papers, record 39480488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39480488

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
PubMed
Journal
J Clin Invest
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
2.23, provisional
iCite
Revised in PubMed
2026-07-03
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sinha SSaptarshi
2Callow BWBrennan W
3Farfel APAlex P
4Roy SSuchismita
5Chen SSiyi
6Masotti MMaria
7Rajendran SShrila
8Buschhaus JMJohanna M
9Espinoza CRCelia R
10Luker KEKathryn E

1 to 10 of 12Source PubMed

See all 12 authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Mesenchymal Stem CellsMajor topic
Connexin 43Major topic
Humans
Female
Animals
Neoplasm Proteins
Mice
Cell Line, Tumor
Coculture Techniques
Receptors, Estrogen
Bone Marrow Neoplasms

Source PubMed

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R50 CA221807NCI NIH HHSUnited StatesR50CA221807PubMed and NIHNIH RePORTER
P30 CA046592NCI NIH HHSUnited StatesP30CA046592PubMed and NIHNIH RePORTER
R01 CA238042NCI NIH HHSUnited StatesR01CA238042PubMed and NIHNIH RePORTER
R01 CA238023NCI NIH HHSUnited StatesR01CA238023PubMed and NIHNIH RePORTER
R01 CA100768NCI NIH HHSUnited StatesR01CA100768PubMed and NIHNIH RePORTER
R01 CA160911NCI NIH HHSUnited StatesR01CA160911PubMed and NIHNIH RePORTER
S10 OD026929NIH HHSUnited StatesS10OD026929PubMed and NIHNIH RePORTER
R33 CA225549NCI NIH HHSUnited StatesR33CA225549PubMed and NIHNIH RePORTER
U01 CA210152NCI NIH HHSUnited StatesU01CA210152PubMed and NIHNIH RePORTER
R37 CA222563NCI NIH HHSUnited StatesR37CA222563PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of36,993,616Breast Cancers That Disseminate to Bone Marrow Acquire Aggressive Phenotypes through CX43-related Tumor-Stroma Tunnels.https://conductscience.org/library/papers/36993616

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42,744,868Immune remodeling and myeloid signature in the bone marrow niche of MYCN-driven neuroblastoma.BJC Rep2026https://conductscience.org/library/papers/42744868PubMed
42,360,909FGF18 mediates fibroblast-leukemia cross talk to promote acute myeloid leukemia progression.Blood2026https://conductscience.org/library/papers/42360909PubMed
42,135,933Tunnelling Nanotube-Mediated Lysosome Sharing Promotes Osteocyte Survival via Transcellular Autophagy.Cell Prolif2026https://conductscience.org/library/papers/42135933PubMed
42,126,612Disrupting oncogenic signaling in triple negative breast cancer: The interplay of Cx43, Pyk2, and Src in MDA-MB-231 cells.Cell Tissue Res2026https://conductscience.org/library/papers/42126612PubMed
41,827,943Lipid Metabolism and Ferroptosis Resistance in Dormant Breast Cancer Cells: Emerging Therapeutic Vulnerabilities.Diagnostics (Basel)2026https://conductscience.org/library/papers/41827943PubMed
41,639,740Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential.Biomark Res2026https://conductscience.org/library/papers/41639740PubMed
41,596,432Bone Metastasis in Estrogen Receptor-Positive Breast Cancer: Molecular Insights and Therapeutic Advances.Int J Mol Sci2026https://conductscience.org/library/papers/41596432PubMed
41,463,174The Cx43-Mediated Autophagy Mechanism Influences Triple-Negative Breast Cancer Through the Regulation of Rab31.Cancers (Basel)2025https://conductscience.org/library/papers/41463174PubMed
41,165,026Liquid Biopsy in Hematologic Malignancies: Advances, Challenges, and Future Directions.Asia Pac J Clin Oncol2026https://conductscience.org/library/papers/41165026PubMed
40,676,710Tumor-associated mesenchymal stem/stromal cells in tumor microenvironment and carcinogenesis.Exp Hematol Oncol2025https://conductscience.org/library/papers/40676710PubMed

1 to 10 of 13

See all 13 cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCDC88A55,704PubTator's text mininghttps://conductscience.org/library/genes/55704NCBI Gene
EREG2,069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12,099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
GJA12,697PubTator's text mininghttps://conductscience.org/library/genes/2697NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39480488

GET https://conductscience.org/api/papers/v1/39480488/authors